1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Recombinant Erythropoietin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 rhEPO 1.2.3 Erythropoiesis-Stimulating Agents (ESA) 1.3 Market by Application 1.3.1 Global Recombinant Erythropoietin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Chronic Kidney Disease 1.3.3 Cancer Related Anemia 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Recombinant Erythropoietin Market Perspective (2017-2028) 2.2 Recombinant Erythropoietin Growth Trends by Region 2.2.1 Recombinant Erythropoietin Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Recombinant Erythropoietin Historic Market Size by Region (2017-2022) 2.2.3 Recombinant Erythropoietin Forecasted Market Size by Region (2023-2028) 2.3 Recombinant Erythropoietin Market Dynamics 2.3.1 Recombinant Erythropoietin Industry Trends 2.3.2 Recombinant Erythropoietin Market Drivers 2.3.3 Recombinant Erythropoietin Market Challenges 2.3.4 Recombinant Erythropoietin Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Recombinant Erythropoietin Players by Revenue 3.1.1 Global Top Recombinant Erythropoietin Players by Revenue (2017-2022) 3.1.2 Global Recombinant Erythropoietin Revenue Market Share by Players (2017-2022) 3.2 Global Recombinant Erythropoietin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Recombinant Erythropoietin Revenue 3.4 Global Recombinant Erythropoietin Market Concentration Ratio 3.4.1 Global Recombinant Erythropoietin Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Recombinant Erythropoietin Revenue in 2021 3.5 Recombinant Erythropoietin Key Players Head office and Area Served 3.6 Key Players Recombinant Erythropoietin Product Solution and Service 3.7 Date of Enter into Recombinant Erythropoietin Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Recombinant Erythropoietin Breakdown Data by Type 4.1 Global Recombinant Erythropoietin Historic Market Size by Type (2017-2022) 4.2 Global Recombinant Erythropoietin Forecasted Market Size by Type (2023-2028) 5 Recombinant Erythropoietin Breakdown Data by Application 5.1 Global Recombinant Erythropoietin Historic Market Size by Application (2017-2022) 5.2 Global Recombinant Erythropoietin Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Recombinant Erythropoietin Market Size (2017-2028) 6.2 North America Recombinant Erythropoietin Market Size by Type 6.2.1 North America Recombinant Erythropoietin Market Size by Type (2017-2022) 6.2.2 North America Recombinant Erythropoietin Market Size by Type (2023-2028) 6.2.3 North America Recombinant Erythropoietin Market Share by Type (2017-2028) 6.3 North America Recombinant Erythropoietin Market Size by Application 6.3.1 North America Recombinant Erythropoietin Market Size by Application (2017-2022) 6.3.2 North America Recombinant Erythropoietin Market Size by Application (2023-2028) 6.3.3 North America Recombinant Erythropoietin Market Share by Application (2017-2028) 6.4 North America Recombinant Erythropoietin Market Size by Country 6.4.1 North America Recombinant Erythropoietin Market Size by Country (2017-2022) 6.4.2 North America Recombinant Erythropoietin Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Recombinant Erythropoietin Market Size (2017-2028) 7.2 Europe Recombinant Erythropoietin Market Size by Type 7.2.1 Europe Recombinant Erythropoietin Market Size by Type (2017-2022) 7.2.2 Europe Recombinant Erythropoietin Market Size by Type (2023-2028) 7.2.3 Europe Recombinant Erythropoietin Market Share by Type (2017-2028) 7.3 Europe Recombinant Erythropoietin Market Size by Application 7.3.1 Europe Recombinant Erythropoietin Market Size by Application (2017-2022) 7.3.2 Europe Recombinant Erythropoietin Market Size by Application (2023-2028) 7.3.3 Europe Recombinant Erythropoietin Market Share by Application (2017-2028) 7.4 Europe Recombinant Erythropoietin Market Size by Country 7.4.1 Europe Recombinant Erythropoietin Market Size by Country (2017-2022) 7.4.2 Europe Recombinant Erythropoietin Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Recombinant Erythropoietin Market Size (2017-2028) 8.2 Asia-Pacific Recombinant Erythropoietin Market Size by Type 8.2.1 Asia-Pacific Recombinant Erythropoietin Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Recombinant Erythropoietin Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Recombinant Erythropoietin Market Share by Type (2017-2028) 8.3 Asia-Pacific Recombinant Erythropoietin Market Size by Application 8.3.1 Asia-Pacific Recombinant Erythropoietin Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Recombinant Erythropoietin Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Recombinant Erythropoietin Market Share by Application (2017-2028) 8.4 Asia-Pacific Recombinant Erythropoietin Market Size by Region 8.4.1 Asia-Pacific Recombinant Erythropoietin Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Recombinant Erythropoietin Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Recombinant Erythropoietin Market Size (2017-2028) 9.2 Latin America Recombinant Erythropoietin Market Size by Type 9.2.1 Latin America Recombinant Erythropoietin Market Size by Type (2017-2022) 9.2.2 Latin America Recombinant Erythropoietin Market Size by Type (2023-2028) 9.2.3 Latin America Recombinant Erythropoietin Market Share by Type (2017-2028) 9.3 Latin America Recombinant Erythropoietin Market Size by Application 9.3.1 Latin America Recombinant Erythropoietin Market Size by Application (2017-2022) 9.3.2 Latin America Recombinant Erythropoietin Market Size by Application (2023-2028) 9.3.3 Latin America Recombinant Erythropoietin Market Share by Application (2017-2028) 9.4 Latin America Recombinant Erythropoietin Market Size by Country 9.4.1 Latin America Recombinant Erythropoietin Market Size by Country (2017-2022) 9.4.2 Latin America Recombinant Erythropoietin Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Recombinant Erythropoietin Market Size (2017-2028) 10.2 Middle East & Africa Recombinant Erythropoietin Market Size by Type 10.2.1 Middle East & Africa Recombinant Erythropoietin Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Recombinant Erythropoietin Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Recombinant Erythropoietin Market Share by Type (2017-2028) 10.3 Middle East & Africa Recombinant Erythropoietin Market Size by Application 10.3.1 Middle East & Africa Recombinant Erythropoietin Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Recombinant Erythropoietin Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Recombinant Erythropoietin Market Share by Application (2017-2028) 10.4 Middle East & Africa Recombinant Erythropoietin Market Size by Country 10.4.1 Middle East & Africa Recombinant Erythropoietin Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Recombinant Erythropoietin Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Details 11.1.2 Amgen Business Overview 11.1.3 Amgen Recombinant Erythropoietin Introduction 11.1.4 Amgen Revenue in Recombinant Erythropoietin Business (2017-2022) 11.1.5 Amgen Recent Developments 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Details 11.2.2 Johnson & Johnson Business Overview 11.2.3 Johnson & Johnson Recombinant Erythropoietin Introduction 11.2.4 Johnson & Johnson Revenue in Recombinant Erythropoietin Business (2017-2022) 11.2.5 Johnson & Johnson Recent Developments 11.3 Kyowa Hakko Kirin 11.3.1 Kyowa Hakko Kirin Company Details 11.3.2 Kyowa Hakko Kirin Business Overview 11.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Introduction 11.3.4 Kyowa Hakko Kirin Revenue in Recombinant Erythropoietin Business (2017-2022) 11.3.5 Kyowa Hakko Kirin Recent Developments 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Recombinant Erythropoietin Introduction 11.4.4 Roche Revenue in Recombinant Erythropoietin Business (2017-2022) 11.4.5 Roche Recent Developments 11.5 3SBio Group 11.5.1 3SBio Group Company Details 11.5.2 3SBio Group Business Overview 11.5.3 3SBio Group Recombinant Erythropoietin Introduction 11.5.4 3SBio Group Revenue in Recombinant Erythropoietin Business (2017-2022) 11.5.5 3SBio Group Recent Developments 11.6 Celltrion, Inc 11.6.1 Celltrion, Inc Company Details 11.6.2 Celltrion, Inc Business Overview 11.6.3 Celltrion, Inc Recombinant Erythropoietin Introduction 11.6.4 Celltrion, Inc Revenue in Recombinant Erythropoietin Business (2017-2022) 11.6.5 Celltrion, Inc Recent Developments 11.7 Teva Pharmaceutical Industries Ltd 11.7.1 Teva Pharmaceutical Industries Ltd Company Details 11.7.2 Teva Pharmaceutical Industries Ltd Business Overview 11.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Introduction 11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) 11.7.5 Teva Pharmaceutical Industries Ltd Recent Developments 11.8 F. Hoffmann-La Roche Ltd 11.8.1 F. Hoffmann-La Roche Ltd Company Details 11.8.2 F. Hoffmann-La Roche Ltd Business Overview 11.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Introduction 11.8.4 F. Hoffmann-La Roche Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) 11.8.5 F. Hoffmann-La Roche Ltd Recent Developments 11.9 LG Life Sciences Ltd 11.9.1 LG Life Sciences Ltd Company Details 11.9.2 LG Life Sciences Ltd Business Overview 11.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Introduction 11.9.4 LG Life Sciences Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) 11.9.5 LG Life Sciences Ltd Recent Developments 11.10 Biocon Limited 11.10.1 Biocon Limited Company Details 11.10.2 Biocon Limited Business Overview 11.10.3 Biocon Limited Recombinant Erythropoietin Introduction 11.10.4 Biocon Limited Revenue in Recombinant Erythropoietin Business (2017-2022) 11.10.5 Biocon Limited Recent Developments 11.11 Intas Pharmaceuticals Ltd 11.11.1 Intas Pharmaceuticals Ltd Company Details 11.11.2 Intas Pharmaceuticals Ltd Business Overview 11.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Introduction 11.11.4 Intas Pharmaceuticals Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) 11.11.5 Intas Pharmaceuticals Ltd Recent Developments 11.12 Sun Pharmaceutical Industries Ltd 11.12.1 Sun Pharmaceutical Industries Ltd Company Details 11.12.2 Sun Pharmaceutical Industries Ltd Business Overview 11.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Introduction 11.12.4 Sun Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) 11.12.5 Sun Pharmaceutical Industries Ltd Recent Developments 11.13 Dr. Reddy's Laboratories Ltd 11.13.1 Dr. Reddy's Laboratories Ltd Company Details 11.13.2 Dr. Reddy's Laboratories Ltd Business Overview 11.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Introduction 11.13.4 Dr. Reddy's Laboratories Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) 11.13.5 Dr. Reddy's Laboratories Ltd Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Recombinant Erythropoietin Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of rhEPO Table 3. Key Players of Erythropoiesis-Stimulating Agents (ESA) Table 4. Global Recombinant Erythropoietin Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Recombinant Erythropoietin Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Recombinant Erythropoietin Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Recombinant Erythropoietin Market Share by Region (2017-2022) Table 8. Global Recombinant Erythropoietin Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Recombinant Erythropoietin Market Share by Region (2023-2028) Table 10. Recombinant Erythropoietin Market Trends Table 11. Recombinant Erythropoietin Market Drivers Table 12. Recombinant Erythropoietin Market Challenges Table 13. Recombinant Erythropoietin Market Restraints Table 14. Global Recombinant Erythropoietin Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Recombinant Erythropoietin Revenue Share by Players (2017-2022) Table 16. Global Top Recombinant Erythropoietin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Erythropoietin as of 2021) Table 17. Ranking of Global Top Recombinant Erythropoietin Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Recombinant Erythropoietin Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Recombinant Erythropoietin Product Solution and Service Table 21. Date of Enter into Recombinant Erythropoietin Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Recombinant Erythropoietin Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Recombinant Erythropoietin Revenue Market Share by Type (2017-2022) Table 25. Global Recombinant Erythropoietin Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Recombinant Erythropoietin Revenue Market Share by Type (2023-2028) Table 27. Global Recombinant Erythropoietin Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Recombinant Erythropoietin Revenue Share by Application (2017-2022) Table 29. Global Recombinant Erythropoietin Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Recombinant Erythropoietin Revenue Share by Application (2023-2028) Table 31. North America Recombinant Erythropoietin Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Recombinant Erythropoietin Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Recombinant Erythropoietin Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Recombinant Erythropoietin Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Recombinant Erythropoietin Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Recombinant Erythropoietin Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Recombinant Erythropoietin Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Recombinant Erythropoietin Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Recombinant Erythropoietin Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Recombinant Erythropoietin Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Recombinant Erythropoietin Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Recombinant Erythropoietin Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Recombinant Erythropoietin Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Recombinant Erythropoietin Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Recombinant Erythropoietin Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Recombinant Erythropoietin Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Recombinant Erythropoietin Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Recombinant Erythropoietin Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Recombinant Erythropoietin Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Recombinant Erythropoietin Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Recombinant Erythropoietin Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Recombinant Erythropoietin Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Recombinant Erythropoietin Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Recombinant Erythropoietin Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Recombinant Erythropoietin Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Recombinant Erythropoietin Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Recombinant Erythropoietin Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Recombinant Erythropoietin Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Recombinant Erythropoietin Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Recombinant Erythropoietin Market Size by Country (2023-2028) & (US$ Million) Table 61. Amgen Company Details Table 62. Amgen Business Overview Table 63. Amgen Recombinant Erythropoietin Product Table 64. Amgen Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 65. Amgen Recent Developments Table 66. Johnson & Johnson Company Details Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Recombinant Erythropoietin Product Table 69. Johnson & Johnson Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 70. Johnson & Johnson Recent Developments Table 71. Kyowa Hakko Kirin Company Details Table 72. Kyowa Hakko Kirin Business Overview Table 73. Kyowa Hakko Kirin Recombinant Erythropoietin Product Table 74. Kyowa Hakko Kirin Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 75. Kyowa Hakko Kirin Recent Developments Table 76. Roche Company Details Table 77. Roche Business Overview Table 78. Roche Recombinant Erythropoietin Product Table 79. Roche Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 80. Roche Recent Developments Table 81. 3SBio Group Company Details Table 82. 3SBio Group Business Overview Table 83. 3SBio Group Recombinant Erythropoietin Product Table 84. 3SBio Group Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 85. 3SBio Group Recent Developments Table 86. Celltrion, Inc Company Details Table 87. Celltrion, Inc Business Overview Table 88. Celltrion, Inc Recombinant Erythropoietin Product Table 89. Celltrion, Inc Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 90. Celltrion, Inc Recent Developments Table 91. Teva Pharmaceutical Industries Ltd Company Details Table 92. Teva Pharmaceutical Industries Ltd Business Overview Table 93. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Table 94. Teva Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 95. Teva Pharmaceutical Industries Ltd Recent Developments Table 96. F. Hoffmann-La Roche Ltd Company Details Table 97. F. Hoffmann-La Roche Ltd Business Overview Table 98. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Product Table 99. F. Hoffmann-La Roche Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 100. F. Hoffmann-La Roche Ltd Recent Developments Table 101. LG Life Sciences Ltd Company Details Table 102. LG Life Sciences Ltd Business Overview Table 103. LG Life Sciences Ltd Recombinant Erythropoietin Product Table 104. LG Life Sciences Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 105. LG Life Sciences Ltd Recent Developments Table 106. Biocon Limited Company Details Table 107. Biocon Limited Business Overview Table 108. Biocon Limited Recombinant Erythropoietin Product Table 109. Biocon Limited Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 110. Biocon Limited Recent Developments Table 111. Intas Pharmaceuticals Ltd Company Details Table 112. Intas Pharmaceuticals Ltd Business Overview Table 113. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Product Table 114. Intas Pharmaceuticals Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 115. Intas Pharmaceuticals Ltd Recent Developments Table 116. Sun Pharmaceutical Industries Ltd Company Details Table 117. Sun Pharmaceutical Industries Ltd Business Overview Table 118. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Table 119. Sun Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 120. Sun Pharmaceutical Industries Ltd Recent Developments Table 121. Dr. Reddy's Laboratories Ltd Company Details Table 122. Dr. Reddy's Laboratories Ltd Business Overview Table 123. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Product Table 124. Dr. Reddy's Laboratories Ltd Revenue in Recombinant Erythropoietin Business (2017-2022) & (US$ Million) Table 125. Dr. Reddy's Laboratories Ltd Recent Developments Table 126. Research Programs/Design for This Report Table 127. Key Data Information from Secondary Sources Table 128. Key Data Information from Primary Sources List of Figures Figure 1. Global Recombinant Erythropoietin Market Share by Type: 2021 VS 2028 Figure 2. rhEPO Features Figure 3. Erythropoiesis-Stimulating Agents (ESA) Features Figure 4. Global Recombinant Erythropoietin Market Share by Application: 2021 VS 2028 Figure 5. Chronic Kidney Disease Case Studies Figure 6. Cancer Related Anemia Case Studies Figure 7. Others Case Studies Figure 8. Recombinant Erythropoietin Report Years Considered Figure 9. Global Recombinant Erythropoietin Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Recombinant Erythropoietin Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Recombinant Erythropoietin Market Share by Region: 2021 VS 2028 Figure 12. Global Recombinant Erythropoietin Market Share by Players in 2021 Figure 13. Global Top Recombinant Erythropoietin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Erythropoietin as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Recombinant Erythropoietin Revenue in 2021 Figure 15. North America Recombinant Erythropoietin Market Size YoY (2017-2028) & (US$ Million) Figure 16. North America Recombinant Erythropoietin Market Size Market Share by Type (2017-2028) Figure 17. North America Recombinant Erythropoietin Market Size Market Share by Application (2017-2028) Figure 18. North America Recombinant Erythropoietin Market Size Share by Country (2017-2028) Figure 19. United States Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Recombinant Erythropoietin Market Size YoY (2017-2028) & (US$ Million) Figure 22. Europe Recombinant Erythropoietin Market Size Market Share by Type (2017-2028) Figure 23. Europe Recombinant Erythropoietin Market Size Market Share by Application (2017-2028) Figure 24. Europe Recombinant Erythropoietin Market Size Share by Country (2017-2028) Figure 25. Germany Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Recombinant Erythropoietin Market Size YoY (2017-2028) & (US$ Million) Figure 32. Asia Pacific Recombinant Erythropoietin Market Size Market Share by Type (2017-2028) Figure 33. Asia Pacific Recombinant Erythropoietin Market Size Market Share by Application (2017-2028) Figure 34. Asia Pacific Recombinant Erythropoietin Market Size Share by Region (2017-2028) Figure 35. China Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Japan Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. South Korea Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Southeast Asia Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. India Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Australia Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 41. Latin America Recombinant Erythropoietin Market Size YoY (2017-2028) & (US$ Million) Figure 42. Latin America Recombinant Erythropoietin Market Size Market Share by Type (2017-2028) Figure 43. Latin America Recombinant Erythropoietin Market Size Market Share by Application (2017-2028) Figure 44. Latin America Recombinant Erythropoietin Market Size Share by Country (2017-2028) Figure 45. Mexico Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Brazil Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Middle East & Africa Recombinant Erythropoietin Market Size YoY (2017-2028) & (US$ Million) Figure 48. Middle East and Africa Recombinant Erythropoietin Market Size Market Share by Type (2017-2028) Figure 49. Middle East and Africa Recombinant Erythropoietin Market Size Market Share by Application (2017-2028) Figure 50. Middle East and Africa Recombinant Erythropoietin Market Size Share by Country (2017-2028) Figure 51. Turkey Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. UAE Recombinant Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Amgen Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 55. Johnson & Johnson Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 56. Kyowa Hakko Kirin Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 57. Roche Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 58. 3SBio Group Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 59. Celltrion, Inc Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 60. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 61. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 62. LG Life Sciences Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 63. Biocon Limited Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 64. Intas Pharmaceuticals Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 65. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 66. Dr. Reddy's Laboratories Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2017-2022) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Amgen Johnson & Johnson Kyowa Hakko Kirin Roche 3SBio Group Celltrion, Inc Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche Ltd LG Life Sciences Ltd Biocon Limited Intas Pharmaceuticals Ltd Sun Pharmaceutical Industries Ltd Dr. Reddy's Laboratories Ltd